Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
This guide compares risk levels between bonds and stocks in retirement, outlining factors like market cycles, duration, and income needs.
28,627 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Dividend-focused investors face a unique puzzle with Boeing: potential for future income vs. exposure to cyclic risk....
Rivian is targeting a major production shift with the R2 lineup. This guide weighs the bull and bear cases for rivian...
Berkshire Hathaway owns a big slice of Apple, and that slice throws off dividend income. This deep dive breaks down w...
China’s birth rate just dropped to its lowest level in decades, setting off alarms about the country’s capacity to ma...
A high-flying semiconductor stock grabbed headlines as it soared. Yet one large investor chose to sell an $89 million...
Vistra's Q1 2026 results shed light on margin dynamics across generation, retail, and renewables. This guide breaks d...
When Broadcom's guidance disappointed, a sudden market pullback opened a legitimate AI buying opportunity. This artic...
A veteran hedge-fund manager behind an early SpaceX investment argues the AI-driven bottleneck trade is fading, trigg...
A new poll in 2026 finds a rising minority of Gen Z workers would prefer a robot supervisor, challenging traditional ...
In a volatile market, a strategically chosen oil major could outperform the S&P 500 in the latter half of 2026. This ...
ASML and Applied Materials ride an AI-capex wave, but their business models diverge. ASML benefits from EUV pricing p...